Fate Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning, everyone, and thanks for joining us at the Morgan Stanley Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. And it's my pleasure to introduce Scott Wolchko, CEO; and Ed Dulac, CFO, from Fate Therapeutics.
Just as a quick reminder, the format for today is a fireside chat. So please feel free to submit a question through the portal if you have one, and we'll be sure to address it in our conversation.
But before we get started, I just need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
So with that, we can jump right into the Q&A. So Scott and Ed, thanks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |